Lund Melanoma Study Group
71 – 80 of 257
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Dialysis as a Novel Adjuvant Treatment for Malignant Cancers
- Contribution to journal › Scientific review
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
- Contribution to journal › Article
-
Mark
Transcriptomic signatures of tumors undergoing T cell attack
- Contribution to journal › Article
-
Mark
Copy number variants are ovarian cancer risk alleles at known and novel risk loci
- Contribution to journal › Article
- 2021
-
Mark
Multiple primary melanoma incidence trends over five decades, a nation-wide population-based study
- Contribution to journal › Article
-
Mark
Breast cancer risk factors and survival by tumor subtype : pooled analyses from the Breast Cancer Association Consortium
(2021) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30(4). p.623-642
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
- Contribution to journal › Article
-
Mark
Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
- Contribution to journal › Article
-
Mark
Non-radical primary diagnostic biopsies affect survival in cutaneous head and neck melanoma
- Contribution to journal › Article
